Stock CPH CIPHER PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Cipher Pharmaceuticals Inc.

Equities

CPH

CA17253X1050

Market Closed - Toronto S.E.
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
8.76 CAD -2.56% Intraday chart for Cipher Pharmaceuticals Inc. +0.92% +58.12%
May. 13 Cipher Pharmaceuticals Downgraded to Hold at Stifel GMP Following Share-Price Gains; Price Target Raised to C$9.50 MT
May. 10 Transcript : Cipher Pharmaceuticals Inc., Q1 2024 Earnings Call, May 10, 2024

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Cipher Pharmaceuticals Downgraded to Hold at Stifel GMP Following Share-Price Gains; Price Target Raised to C$9.50
MT
Transcript : Cipher Pharmaceuticals Inc., Q1 2024 Earnings Call, May 10, 2024
Cipher Pharmaceuticals : Financial Document
PU
Cipher Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Cipher Pharmaceuticals Reports First Quarter 2024 Results
AQ
Cipher Pharmaceuticals Schedules Q1 2024 Earnings Release and Conference Call
AQ
Cipher Pharmaceuticals Schedules Q1 2024 Earnings Release and Conference Call
AQ
Cipher Pharmaceuticals Announces Participation in the 2024 Bloom Burton & Co. Healthcare Investor Conference
NE
Transcript : Cipher Pharmaceuticals Inc., Q4 2023 Earnings Call, Mar 15, 2024
Tranche Update on Cipher Pharmaceuticals Inc.'s Equity Buyback Plan announced on November 15, 2023.
CI
Cipher Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Cipher Pharmaceuticals Q4 Profit Falls 61% on Charges
MT
Cipher Pharmaceuticals Brief: Q4 Net income and earnings per common share were US$7.7 million and $0.32, respectively
MT
Cipher Pharmaceuticals Brief: Q4 Total revenue was US$4.9 million, consistent with Q4 2022
MT
Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results
AQ
Cipher Pharmaceuticals Schedules Q4 2023 Earnings Release and Conference Call
AQ
Cipher Pharmaceuticals Upgraded to Buy at Stifel GMP; Price Target Raised to C$8.00
MT
Cipher Pharmaceuticals Brief: Announcing that its common shares are now trading on the OTCQX Best Market
MT
Cipher Pharmaceuticals Announces the Commencement of OTCQX Trading
AQ
Cipher Pharmaceuticals Announces Change of Auditor
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CPH Stock
  4. News Cipher Pharmaceuticals Inc.